Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-17

Clinical Trial Update: REperfusion With Cooling in CerebraL Acute IscheMia II [Phase 2]

View source ↗

Summary

Phase 2 trial investigating reperfusion with cooling for acute ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: WellStar Health System | Conditions: Ischemic Stroke, Hypothermia | Phase 2 | Status: WITHDRAWN